SCHEMBL361736

SCHEMBL361736

CC(=O)Oc1cc(O)ccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.57
CYP3A4 P08684 1/20 0.50
PIM1 P11309 1/20 0.49
CA12 O43570 4/20 0.46
CA1 P00915 4/20 0.46
CA2 P00918 4/20 0.46
CA7 P43166 4/20 0.46
CA9 Q16790 4/20 0.46
CA14 Q9ULX7 4/20 0.46
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TSHR P16473 2/20 0.44
GAA P10253 1/20 0.44
RAB9A P51151 1/20 0.44
PREP P48147 3/20 0.43
CFD P00746 1/20 0.43
CELA1 Q9UNI1 1/20 0.43
PTGS2 P35354 2/20 0.42
ALOX5 P09917 1/20 0.42
TNFSF11 O14788 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12094224 0.85 TSHR (0.60) CYP3A4PIM1CA12CA9KDM4E
SCHEMBL511275 0.83 CYP3A4 (0.50) MAOBCYP3A4PIM1CA12CA1
SCHEMBL13950674 0.82 LMNA (0.50) MAOBPIM1KDM4EALDH1A1TSHR
SCHEMBL8765708 0.82 KDM4E (0.62) CYP3A4PIM1CA12CA2CA9
SCHEMBL13176949 0.82 ACHE (0.61) MAOBCYP3A4KDM4EALDH1A1TSHR
SCHEMBL3245649 0.82 PIM1 (0.47) CYP3A4PIM1CA1CA2KDM4E
SCHEMBL8995644 0.81 MAOB (0.54) MAOBCA12CA1CA2CA7
SCHEMBL18130081 0.81 ABCB1 (0.57) MAOBCYP3A4CA12CA1CA2
SCHEMBL4274421 0.81 APP (0.43) MAOBCYP3A4PIM1RAB9APREP
SCHEMBL18130083 0.81 ABCB1 (0.57) MAOBCYP3A4CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11406678-B2 Simmondsin formulation Raes, Stefaan (BE) 2022-08-09 US claimed
CN-114144454-A Improved operating time to open-run time ratio by adding phenolic catalysts to polyaspartic flooring formulations 科思创有限公司 2022-03-04 CN claimed
EP-3452095-B1 SIMMONDSIN FORMULATION Van Den Driessche Herman (BE) 2021-04-07 EP claimed
EP-3452095-A2 SIMMONDSIN FORMULATION Van den Driessche, Herman (BE) 2019-03-13 EP claimed
US-20190070238-A1 SIMMONDSIN FORMULATION VAN DEN DRIESSCHE, HERMAN (BE) 2019-03-07 US claimed
WO-2017191501-A2 SIMMONDSIN FORMULATION D'OOSTERLYNCK ANDRÉ (BE) 2017-11-09 WO claimed
US-9695278-B2 Polyester co-phosphonates FRX POLYMERS, INC. (US) 2017-07-04 US claimed
EP-2867272-A1 POLYESTER CO-PHOSPHONATES FRX Polymers, Inc. (US) 2015-05-06 EP claimed
WO-2014005136-A1 POLYESTER CO-PHOSPHONATES FRX POLYMERS, INC. (US) 2014-01-03 WO claimed
US-20140000751-A1 POLYESTER CO-PHOSPHONATES DOSKOCIL MANUFACTURING COMPANY, INC. 2014-01-02 US claimed
US-4782132-A Process for producing a copolyester MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1988-11-01 US claimed
CN-114829450-B Method for producing liquid crystalline polyester and liquid crystalline polyester 住友化学株式会社 2024-08-16 CN disclosed
US-11718747-B2 Nanoparticle containing compositions EVONIK OPERATIONS GMBH (DE) 2023-08-08 US disclosed
US-20230069551-A1 METHOD FOR PRODUCING LIQUID CRYSTALLINE POLYESTER AND LIQUID CRYSTALLINE POLYESTER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-02 US disclosed
US-11406678-B2 Simmondsin formulation Raes, Stefaan (BE) 2022-08-09 US disclosed
US-4782132-A Process for producing a copolyester MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1988-11-01 US disclosed
EP-0286444-A2 Process for producing a liquid crystalline polyester of a cyclohexanedicarboxylic acid and an aromatic diol Chisso Corporation (JP) 1988-10-12 EP disclosed
EP-0227487-A2 Positive type radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1987-07-01 EP disclosed
US-4168980-A SILVER IMIDAZOLINE-2-THIONE EASTMAN KODAK COMPANY (US) 1979-09-25 US disclosed
US-3985564-A Photographic element and process for developing EASTMAN KODAK COMPANY (US) 1976-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190070238-A1 SIMMONDSIN FORMULATION SPIN2B, SNCA, CHKB MAOB 288/4885CYP3A4 2789/4885PIM1 4389/4885
US-11406678-B2 Simmondsin formulation SPIN2B, SNCA, CHKB MAOB 288/4885CYP3A4 2789/4885PIM1 4389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.